HQP8361 / Merck (MSD), Ascentage Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
HQP8361 / Merck (MSD), Ascentage Pharma
NCT00559182: A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001)

Completed
1
47
NA
Comparator: MK-8033, Comparator: MK-8033 +/- omeprazole
Merck Sharp & Dohme LLC
Advanced Cancer
06/10
07/10

Download Options